Clinical Trials Logo

Filter by:
NCT ID: NCT04363073 Completed - Breast Feeding Clinical Trials

Assessment of Annabella Breast Pump Performance

Start date: December 30, 2020
Phase: N/A
Study type: Interventional

This is an interventional, prospective, randomized, comparative, two-period cross over study to evaluate the performance of Annabella breast pump against a control breast pump.

NCT ID: NCT04360746 Completed - Hip Fractures Clinical Trials

The Influence of Clinical Pharmacist on the Quality of Drug Prescribing and Rehabilitation Outcomes in Post-acute Hip Fractured Patients

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

The influence of clinical pharmacist on various drug related outcomes was reported in different healthcare setting including the community, long term care and during acute hospitalization. Nevertheless, data on the influence of clinical pharmacist intervention on the quality of drug prescribing and rehabilitation outcomes in post-acute hip fractured patients is scarce. The aims of the current study are to evaluate the contribution of a clinical pharmacist on the appropriateness of drug prescribing among post-acute geriatric hip fractured patients and to investigate whether this involvement can improve rehabilitation outcomes. The investigators hypothesis is that early review of geriatric hip fractured patients medical record by a clinical pharmacist will improve the appropriateness of drug treatment and the rehabilitation outcomes among this population.

NCT ID: NCT04358926 Completed - COVID-19 Clinical Trials

Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)

HBOTCOVID19
Start date: April 30, 2020
Phase: N/A
Study type: Interventional

The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic.So far, no specific treatment has proven efficacy. Recent case series reported the use of Hyperbaric Oxygen Therapy (HBOT) on 5 severe COVID-19 patients who developed respiratory insufficiency. HBOT mechanisms of tissue oxygenation and anti-inflammatory effect may explain these findings. The purpose of the current study is the evaluate the efficacy of HBOT in moderate-severe COVID-19 patients in a randomized controlled manner.

NCT ID: NCT04358796 Completed - Clinical trials for Hyperbaric Oxygen Therapy

Measuring Cognitive Enhancement During Hyperbaric Oxygen Treatments

Start date: November 10, 2017
Phase: N/A
Study type: Interventional

The aim of the current study was to examine the effect of short-term HBOT (hyperbaric oxygen treatments) on a range of cognitive abilities. The current study examined whether there is a HBOT-related short-term cognitive improvement and, if so, what specific cognitive abilities are improved by the intervention. Participants were randomized to perform cognitive tasks in one of two chambers with two different clinical environments: (a) HBOT condition: (2 ATA (atmosphere absolute) 100% oxygen for 90 minutes). (b) Control condition: in which the chamber was not pressurized (Normobaric condition- 1 ATA for 90 minutes).

NCT ID: NCT04353934 Completed - Anxiety Clinical Trials

The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic

TARUS
Start date: March 31, 2020
Phase:
Study type: Observational

Background/Objectives: Psychological anxiety has been associated with alterations in eating patterns. The 2020 global coronavirus pandemic has created a situation characterized by increased anxiety. The present international survey was designed to examine associations between exposure to quarantine/isolation measures, anxiety levels and changes in dietary patterns. Methods: The present study utilizes a Google Survey platform to conduct an international survey querrying dietary patterns before vs. after the coronavirus pandemic; anxiety during the pandemic; and demographic characteristics. The nutrition portion of the survey is based on the Mediterranean Diet Score while the anxiety estimate is based on the GAD-7. The survey is available in English, Hebrew, Spanish, Italian, French, Arabic and Russian. It has been distributed via social media. Anticipated Results: We believe that changes in dietary habits will be identified and that these will be associated with anxiety levels. Additionally, we believe that by-country differences will be identified. Discussion: The Google Survey format distributed by social media provides an almost immediate means of distributing the survey globally. The survey can only be completed if the respondent first indicates his/her informed consent. The convenience sample limits generalizability to individuals who volunteer to complete online surveys; however, we anticipate a large response which may mitigate this limitation.

NCT ID: NCT04353817 Completed - Cystic Fibrosis Clinical Trials

A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes

Start date: June 19, 2020
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of elexacaftor (ELX) / tezacaftor (TEZ) / ivacaftor (IVA) triple combination (TC) in subjects 6 through 11 years of age with cystic fibrosis (CF) who are heterozygous for F508del and a minimal function (MF) mutation (F/MF genotypes).

NCT ID: NCT04353453 Completed - Atrial Fibrillation Clinical Trials

Study to Evaluate the Performance of CardiacSense PPG Sensor

Start date: February 19, 2018
Phase: N/A
Study type: Interventional

study to evaluate the performance of the CardiacSense1's embedded PPG under different environmental and physical conditions

NCT ID: NCT04353219 Completed - Clinical trials for Healthy Runners. Compression Stocking and Performance

The Effect of Compression Stockings During Training on Running Performance

Start date: May 25, 2020
Phase: N/A
Study type: Interventional

Studies that have examined the effects of compression stocking on athlete's performance have been carried out in a single test, i.e., the athlete's was examined during running/riding/jumping with and without the compression stocking. Yet, using the stocking during all training session and for longer period of time might further enhance the performance. Compression stocking were found to have a positive effect on the athlete' recovery. We hypotheses that if the athlete will train with the stocking on a regular basis and his/her recovery will improve, it will also improve the performance. In addition, the athlete's body may need an adjustment period to use the compression stocking. As such, the advantages of using compression stocking might only be revealed after training with the socks during a period of time and not just performing the tests/competitions with it.

NCT ID: NCT04349098 Completed - Clinical trials for Coronavirus Infection

Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection

Coronavirus
Start date: April 17, 2020
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to evaluate the activity of low dose oral selinexor (KPT-330) and to evaluate the clinical recovery, the viral load, length of hospitalization and the rate of morbidity and mortality in participants with severe COVID-19 compared to placebo. The study had 2 arms and evaluated selinexor 20 mg + standard of care (SoC) and placebo + SoC. As the treatment for COVID-19 is rapidly evolving, the SoC varied over time and across regions of the world.

NCT ID: NCT04348422 Completed - COVID-19 Clinical Trials

Evaluating the Immune Response for COVID-19

COVIDIMMUNE
Start date: May 1, 2020
Phase:
Study type: Observational

The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic. The measures in which public health officials quarantine confirmed and isolate symptomatic cases in order to reduce the spread COVID-19 is the common practice used in most countries. However, a significant question remains in regards to the asymptomatically infected individuals, which may propagate the virus and impede infection control. The other question to consider is whether these asymptomatic carriers develop an immune response or continue viral shedding. The purpose of the current study is the evaluate the immune response, i.e developing anti-SARS-CoV-2 antibodies in the asymptomatic cases, in a household study design. We plan to evaluate over 1000 patients with positive COVID-19 results and their households.